The association baseline NIH Stroke Scale score with ABO blood-subtypes in young patients with acute ischemic stroke

Atherosclerosis

Volumn 236, Issue 1, 2014, Pages

  Yang, Ning ^a   Zhang, Bin ^a   Xie, Longchang ^a   Yin, Jianrui ^a   He, Yihua ^a   Yang, Xinguang ^a   Gao, Cong ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Blood groups; Ischemic stroke; NIHSS; Young

Indexed keywords

BLOOD GROUP A ANTIGEN; BLOOD GROUP B ANTIGEN; BLOOD GROUP O ANTIGEN; TRIACYLGLYCEROL; URIC ACID; BLOOD GROUP ABO SYSTEM;

ADULT; ARTICLE; BLOOD GROUP A; BLOOD GROUP ABO SYSTEM; BLOOD GROUP B; BLOOD GROUP O; BLOOD GROUP TYPING; BRAIN ISCHEMIA; CHINESE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROGNOSIS; RANKIN SCALE; SENSITIVITY AND SPECIFICITY; STROKE PATIENT; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; ACUTE DISEASE; ANALYSIS; AREA UNDER THE CURVE; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MODEL; BLOOD; BRAIN DAMAGE, CHRONIC; CHINA; CLASSIFICATION; COMORBIDITY; DISEASE PREDISPOSITION; DYSLIPIDEMIAS; INFLAMMATION; MIDDLE AGED; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ABO BLOOD-GROUP SYSTEM; ACUTE DISEASE; ADULT; AREA UNDER CURVE; ASIAN CONTINENTAL ANCESTRY GROUP; BRAIN DAMAGE, CHRONIC; BRAIN ISCHEMIA; CHINA; COMORBIDITY; DISEASE SUSCEPTIBILITY; DYSLIPIDEMIAS; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MODELS, CARDIOVASCULAR; PATIENT DISCHARGE; PROGNOSIS; RISK FACTORS; ROC CURVE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84905864606     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.06.019     Document Type: Article

References (32)

1. Carpeggiani C., Coceani M., Landi P., Michelassi C., L'Abbate A. ABO blood group alleles: a risk factor for coronary artery disease. An angiographic study. Atherosclerosis 2010, 211:461-466.
2. Herman B., Schmitz P.I., Leyten A.C., Van Luijk J.H., Frenken C.W., Op De Coul A.A., et al. Multivariate logistic analysis of risk factors for stroke in Tilburg, The Netherlands. Am J Epidemiol 1983, 118:514-525.
3. Ionescu D.A., Marcu I., Bicescu E. Cerebral thrombosis, cerebral haemorrhage, and ABO blood-groups. Lancet 1976, 1:278-280.
4. Wu O., Bayoumi N., Vickers M.A., Clark P. ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. JThromb Haemost 2008, 6:62-69.
5. Wang M.M., Lee S.J., Kim J., Majersik J.J., Blaivas M., Borjigin J. ABO blood antigens define human cerebral endothelial diversity. Neuroreport 2013, 24:79-83.
6. Kasner S.E. Clinical interpretation and use of stroke scales. Lancet Neurol 2006, 5:603-612.
7. Frankel M.R., Morgenstern L.B., Kwiatkowski T., Lu M., Tilley B.C., Broderick J.P., et al. Predicting prognosis after stroke: a placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA Stroke Trial. Neurology 2000, 55:952-959.
8. Schlegel D.J., Tanne D., Demchuk A.M., Levine S.R., Kasner S.E. Prediction of hospital disposition after thrombolysis for acute ischemic stroke using the National Institutes of Health Stroke Scale. Arch Neurol 2004, 61:1061-1064.
9. Adams H.P., Bendixen B.H., Kappelle L.J., Biller J., Love B.B., Gordon D.L., et al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. TOAST: trial of Org 10172 in acute stroke treatment. Stroke 1993, 24:35-41.
10. O'Malley T., Langhorne P., Elton R.A., Stewart C. Platelet size in stroke patients. Stroke 1995, 26:995-999.
11. Ducroquet A., Leys D., Al Saabi A., Richard F., Cordonnier C., Girot M., et al. Influence of chronic ethanol consumption on the neurological severity in patients with acute cerebral ischemia. Stroke 2013, 44:2324-2326.
12. Rumsey R.H., Ciesielski D.J. New protocols in serological testing: a review of techniques to meet today's challenges. Immunohaematology 2000, 16:131-137.
13. Lapierre Y., Rigal D., Adam J., Josef D., Meyer F., Greber S., et al. The gel test: a new way to detect red cells antigen-antibody reactions. Transfusion 1990, 30:109-113.
14. Furlan J.C., Vergouwen M.D., Fang J., Silver F.L. White blood cell count is an independent predictor of outcomes after acute ischaemic stroke. Eur J Neurol 2013 Jul 15, 10.1111/ene.12233.
15. Jin R., Yang G., Li G. Inflammatory mechanisms in ischemicstroke: role of inflammatory cells. JLeukoc Biol 2010, 87:779-789.
16. Kolev K., Machovich R. Molecular and cellular modulation of fibrinolysis. Thromb Haemost 2003, 89:610-621.
17. Lichy C., Wagner S., Hacke W., Grau A.J. Thrombolytic properties of leukocytes from peripheral blood in healthy subjects and in patients with acute cerebral ischemia. Thromb Res 2000, 98:29-37.
18. Sarwar N., Gao P., Seshasai S.R., Gobin R., Kaptoge S., Di Angelantonio E., et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010, 375:2215-2222.
19. Ohira T., Shahar E., Chambless L.E., Rosamond W.D., Mosley T.H., Folsom A.R. Risk factors for ischemic stroke subtypes: the atherosclerosis risk in communities study. Stroke 2006, 37:2493-2498.
20. McConnell R., Pyke D., Roberts J.A.F. Blood groups in diabetes mellitus. Br Med J 1956, 1:772-776.
21. Weir C.J., Sattar N., Walters M.R., Lees K.R. Low triglyceride, not low cholesterol concentration independently predicts poor outcome following acute stroke. Cerebrovasc Dis 2003, 16:76-82.
22. Ryu W.S., Lee S.H., Kim C.K., Kim B.J., Yoon B.W. Effects of low serum triglyceride on stroke mortality: a prospective follow-up study. Atherosclerosis 2010, 212:299-304.
23. Eryurek F.G., Surmen E., Oner P., Altug T., Oz H. Gamma-glutamyl transpeptidase and acetylcholinesterase activities in brain capillaries of cholesterol-fed rabbits. Res Commun Chem Pathol Pharmacol 1990, 69:245-248.
24. FOOD Trial Collaboration Poor nutritional status on admission predicts poor outcomes after stroke: observational data from the food trial. Stroke 2003, 34:1450-1456.
25. Contiero E., Chinello G.E., Folin M. Serum lipids and lipoproteins associations with ABO blood groups. Anthropol Anz 1994, 52:221-230.
26. Hink H.U., Santanam N., Dikalov S., McCann L., Nguyen A.D., Parthasarathy S., et al. Peroxidase properties of extracellular superoxide dismutase: role of uric acid in modulating invivo activity. Arterioscler Thromb Vasc Biol 2002, 22:1402-1408.
27. Love S. Oxidative stress in brain ischaemia. Brain Pathol 1999, 9:119-131.
28. Lewandowski C.A., Frankel M., Tomsick T.A., Broderick J., Frey J., Clark W., et al. Combined intravenous and intra-arterial r-TPA versus intraarterial therapy of acute ischemic stroke: emergency management of stroke (ems) bridging trial. Stroke 1999, 30:2598-2605.
29. Hacke W., Albers G., Al-Rawi Y., Bogousslavsky J., Davalos A., Eliasziw M., et al. The desmoteplase in acute ischemic stroke trial (dias): a phase ii mri-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005, 36:66-73. DIAS Study Group.
30. Urra X., Ariño H., Llull L., Amaro S., Obach V., Cervera A., et al. The outcome of patients with mild stroke improves after treatment with systemic thrombolysis. PLoS One 2013, (3):8. e59420. 10.1371/journal.pone.0059420.
31. Yip S.P., Yow C.M., Lewis W.H. DNA polymorphism at the ABO locus in the Chinese population of Hong Kong. Hum Hered 1995, 45:266-271.
32. Asdaghi N., Jeerakathil T., Hameed B., Saini M., McCombe J.A., Shuaib A., et al. Oxfordshire community stroke project classification poorly differentiates small cortical and subcortical infarcts. Stroke 2011, 42(8):2143-2148.